Physician
Family Medicine
Dr. Lisa L. Smith, MD
|
|
Give Review
Lisa Smith is an expert in the field of Family Medicine. He studied medicine at University of Toledo College of Medicine. Lisa Smith is a published MD. He published 20 publications, including: 'The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leuke...' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- ER stress and autophagy: new players in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.
- The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leuke...
- Understanding juror perceptions of forensic evidence: investigating the impact of case context on perceptions of forensic evidence strength.
- The relationship between deprivation and forensic material recovered from stolen vehicles: is it affected by vehicle condition and tidiness?
- Comorbidity and the treatment of principal anxiety disorders in a naturalistic sample.
- Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
- Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease.
- The relationship between deprivation and forensic opportunities with stolen vehicles.
- Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.
- Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia c...
- Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia.
- Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.
- Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untre...
- Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
- A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechan...
- Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.
- Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets.
- Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab.
- A novel beta-lactam antibiotic activates tumor cell apoptotic program by inducing DNA damage.
Schools
Medical College Of Ohio
Flower Hospital
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Group Employees PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Frontpath Health Coalition
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Mutual of Omaha
- Paramount
- Priority PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Toledo College of Medicine
Drug Facts
| NPI NUMBER | 1932104072 | |
| NPPES Provider LastName | SMITH | |
| NPPES Provider FirstName | LISA | |
| NPPES Provider ZIPCode | 436111800 | |
| NPPES Provider State | OH | |
| Specialty Description | Family Practice | |
| Total Claim Count | 273.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932104072 |
| Last Name Of The Provider | SMITH |
| First Name Of The Provider | LISA |
| View All |
Similar Doctors
|
Dr. Kathleen Luce, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Georges T. Jabaly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John O. Uche, MD |
|
|
Dr. Linda M. Speer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Hughes, DO |
|
|
Dr. Christopher M. Davis, MD |
|
|
Dr. James J. Bomer, MD |
|
|
Dr. Rashmi Puri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sarah Wells, CNP |